Research Funding Strategy

Our aims

• To fund research that helps to find the cure or cures
• To fund research that contributes towards finding the cause or causes
• To fund the best quality research
• To fund research that offers better outcomes to men that are diagnosed with prostate cancer
• To enable prostate cancer specialists to share information on a regular basis

History

Prostate Cancer Research Foundation was founded in 1991. The aim of the Foundation is to promote research into the causes of prostate cancer, particularly by linking together scientists and clinicians in all relevant fields throughout the world at biennial forum.
The Foundation has a volunteer scientific and clinical advisory committee with the two-fold purpose of supervising the existing research projects, and evaluating new, worthwhile projects for support. The process of awarding funding is stringent and involves independent peer review of grant applications.

Funding

The Foundation funds research into prostate cancer and will consider applications for up to £100,000, over a maximum of three years
To apply for a grant, research proposals must demonstrate:

Excellence - Usually Alpha rated by peer review process
Sustainability - Conducted in a University, Medical School, hospital
Relevance - Clear pathway from hypothesis to potential alleviation/treatment of prostate cancer
Originality and a clear case of fully justified financial need

The Prostate Cancer Research Foundation is a member of the Association of Medical Research Charities (AMRC) – a membership organisation of the leading medical and health research charities in the UK. www.amrc.org.uk

How we fund research

In July 2006 Prostate Cancer Research Foundation became a member of the Association of Medical Research Charities. In order to be a member we put in place a number of policies relating to peer review and how our scientific committee decide which projects will be given funding.

You can download the following for more information:

Research Strategy

Peer review and conflict of interest policy

Code of conduct for Scientific Committee

The Scientific Committee is made up of the following members:

Dr Christopher Adams (Lay member)
Prof Chris Bangma 
Sir Walter Bodmer
Mr Frank Chinegwundoh
Dr Ros Eeles
Mr Mark Emberton
Emma Halls (Chief Executive)
Prof Norman Maitland
Mr Christopher Woodhouse (Chair)